Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
AssigneeSepracor Inc.
InventorsChrisantha Hugh Senanayake, Qun Kevin Fang, Zhengxu Han, Dhileepkumar Krishnamurthy
Life of this patent
Estimating the term…
Abstract
Methods of making and using racemic and optically pure metabolites of sibutramine, and pharmaceutically acceptable salts, solvates, and clathrates thereof, are disclosed. Pharmaceutical compositions and dosage forms are also disclosed which comprise a dopamine reuptake inhibitor, such as a racemic or optically pure sibutramine metabolite, and optionally an additional pharmacologically active compound.
Claims5
A compound of the formula:
- and pharmaceutically acceptable salts, solvates and clathrates thereof, wherein R is alkyl.
A method of preparing a compound of Formula 2:
- which comprises contacting cyclobutanecarbonitrile with diisobutylaluminum hydride to form an intermediate;
- and reacting the intermediate with CH3NH2 at a temperature and for a time sufficient to form the compound of Formula 2.
A method of preparing racemic or optically pure desmethylsibutramine which comprises contacting a compound of Formula 2 with a compound of the formula AMX, wherein A is aryl, alkyl, or aralkyl, M is Li or Mg, and X is a halogen atom.
Dependencies are inferred from the claim text.